Estabrook Capital Management

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1344717 NEW YORK, NY

Position in VRTX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$34,274

+$3,463 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#1,556

of 1,735 holders

Holding Since

Dec 2021

19 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Estabrook Capital Management holds $236,684 across 3 Biotechnology names. VRTX ranks #3 (14.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	250	$155,885
2	BNTX	BioNTech SE	500	$46,525
3	VRTX	Vertex Pharmaceuticals Inc / Ma This page	69	$34,274

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$34,274	69	0.0%	Shares	Sole	2026-08-13
2026-03-31	$30,811	69	0.0%	Shares	Sole	2026-05-14
2025-12-31	$31,281	69	0.0%	Shares	Sole	2026-02-13
2025-09-30	$27,023	69	0.0%	Shares	Sole	2025-11-10
2025-06-30	$30,718	69	0.0%	Shares	Sole	2025-08-13
2025-03-31	$33,452	69	0.0%	Shares	Sole	2025-05-14
2024-12-31	$27,786	69	0.0%	Shares	Sole	2025-02-13
2024-09-30	$32,090	69	0.0%	Shares	Sole	2024-11-13
2024-06-30	$32,341	69	0.0%	Shares	Sole	2024-08-13
2024-03-31	$28,842	69	0.0%	Shares	Sole	2024-05-14
2023-12-31	$28,075	69	0.0%	Shares	Sole	2024-02-13
2023-09-30	$23,994	69	0.0%	Shares	Sole	2023-11-13
2023-06-30	$24,281	69	0.0%	Shares	Sole	2023-08-11
2023-03-31	$21,739	69	0.0%	Shares	Sole	2023-05-12
2022-12-31	$19,925	69	0.0%	Shares	Sole	2023-02-13
2022-09-30	$19,978	69	0.0%	Shares	Sole	2022-11-14
2022-06-30	$19,443	69	0.0%	Shares	Sole	2022-08-15
2022-03-31	$18,006	69	0.0%	Shares	Sole	2022-05-13
2021-12-31	$15,152	69	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.